Join to View Full Profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-293-6529
Fax+1 614-293-9469
Dr. Roychowdhury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sameek Roychowdhury is an oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from Ohio State University College of Medicine and has been in practice 11 years. He is experienced in hematologic oncology.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2008 - 2011- University of MichiganResidency, Internal Medicine, 2006 - 2008
Ohio State University College of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2012 - 2026
MI State Medical License 2006 - 2013
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing Start of enrollment: 2013 Nov 04
- Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT. Start of enrollment: 2015 Feb 24
- Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations Start of enrollment: 2020 Jan 16
- Join now to see all
Publications & Presentations
PubMed
- Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.Emily L Hoskins, Raven Vella, Julie W Reeser, Michele R Wing, Eric Samorodnitsky
NPJ Precision Oncology. 2025-07-03 - Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial.Chunjie Li, Anne M Noonan, John Hays, Sameek Roychowdhury, Pannaga Malalur
Clinical Cancer Research. 2025-06-03 - Growth factor receptor plasticity drives therapeutic persistence of metastatic breast cancer.Mitchell Ayers, Marvis Monteiro, Aneesha Kulkarni, Julie W Reeser, Emily Dykhuizen
Cell Death & Disease. 2025-04-04
Press Mentions
Research Spotlight by Dr. Anna Berkenblit: July 2025July 23rd, 2025- Sameek Roychowdhury, MD, PhD, on Telemedicine in Clinical TrialsJune 2nd, 2025
- Blood Test for Cancer Now Available, but Is It Ready for Prime Time?August 16th, 2022
- Join now to see all
Grant Support
- Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered CancersOHIO STATE UNIVERSITY2021–2026
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
